ARDENT HEALTH INC (ARDT) Stock Earnings & Estimates
USA - NYSE:ARDT - US03980N1072 - Common Stock
14.68 USD
+0.12 (+0.82%)
14.64 USD
-0.04 (-0.27%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.13B 5.32% | 5.409B 5.45% | 5.966B 10.29% | 6.472B 8.48% | 6.792B 4.94% | 7.188B 5.83% | |
| EBITDA YoY % growth | 338.426M -23.15% | 356.685M 5.40% | 552.05M 54.77% | 607.74M 10.09% | 648.44M 6.70% | 705.35M 8.78% | |
| EBIT YoY % growth | 200.253M -33.95% | 215.843M 7.79% | 405.762M 87.99% | 501.35M 23.56% | 541.23M 7.95% | 574.58M 6.16% | |
| Operating Margin | 3.90% | 3.99% | 6.80% | 7.75% | 7.97% | 7.99% | |
| EPS YoY % growth | N/A | N/A | N/A | 1.88 52.55% | 1.95 4.10% | 2.21 13.28% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.42 145.00% | 0.65 -19.83% | 0.34 18.08% | 0.51 -1.92% | 0.42 0.41% | 0.66 2.09% | 0.40 17.66% | 0.59 15.00% | 0.45 7.32% | 0.79 18.46% |
| Revenue Q2Q % growth | 1.578B 8.84% | 1.69B 5.21% | 1.611B 7.60% | 1.732B 5.27% | 1.677B 6.27% | 1.811B 7.16% | 1.698B 5.40% | 1.833B 5.83% | 1.716B 2.33% | 1.92B 6.02% |
| EBITDA Q2Q % growth | 148.32M -17.05% | 192.01M -36.81% | 129.21M 25.09% | 165.51M -22.22% | 162.45M 9.53% | 201.23M 4.80% | 123.42M -4.48% | 197.88M 19.56% | 172.38M 6.11% | 211.14M 4.92% |
| EBIT Q2Q % growth | 114.15M 62.19% | 159.06M 0.94% | 101.54M 51.35% | 137.89M 0.44% | 134.61M 17.92% | 176.32M 10.85% | 160.09M 57.66% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.52 52.94% | 0.30 | 0.22 | 71.20% |
| Q1 2025 Q2Q % growth | 0.29 | 0.20 | 0.09 | 43.05% |
| Q4 2024 Q2Q % growth | 0.81 | 0.46 | 0.35 | 76.20% |
| Q3 2024 Q2Q % growth | 0.17 | 0.31 | -0.14 | -44.28% |
| Q2 2024 Q2Q % growth | 0.34 | 0.31 | 0.03 | 10.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.645B 11.85% | 1.577B | 68.28M | 4.33% |
| Q1 2025 Q2Q % growth | 1.497B 4.04% | 1.528B | -30.766M | -2.01% |
| Q4 2024 Q2Q % growth | 1.606B | 1.514B | 92.289M | 6.10% |
| Q3 2024 Q2Q % growth | 1.45B | 1.481B | -31.183M | -2.11% |
| Q2 2024 Q2Q % growth | 1.471B | 1.487B | -16.08M | -1.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.07% | -39.85% | -0.16% | -3.94% |
| Revenue | 0% | -4.88% | -0.02% | 0.22% |